Raymond James & Associates 23and Me Holding Co. Transaction History
Raymond James & Associates
- $150 Billion
- Q2 2024
A detailed history of Raymond James & Associates transactions in 23and Me Holding Co. stock. As of the latest transaction made, Raymond James & Associates holds 75,614 shares of ME stock, worth $21,928. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,614
Previous 85,614
11.68%
Holding current value
$21,928
Previous $45,000
35.56%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ME
# of Institutions
159Shares Held
100MCall Options Held
270KPut Options Held
349K-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$5.64 Million18.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$4.47 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY10.2MShares$2.97 Million0.5% of portfolio
-
Sapphire Ventures, L.L.C. Austin, TX5.29MShares$1.53 Million1.76% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.94MShares$1.43 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $75.3M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...